Company intelligence / Profile preview

PeptiStar

Settsu City, Osaka, Japanpeptistar.com ↗

Ownership: Private
Development stage: Other

Overview

PeptiStar is Asia’s leading contract development and manufacturing organization (CDMO) specializing in high-quality peptide and oligonucleotide active pharmaceutical ingredients (APIs). The company offers R&D, production, analytical services, clinical trial support, and regulatory application support for both traditional and complex peptides—including macrocyclic/stapled peptides with non-natural amino acids—and oligonucleotides. It serves global pharmaceutical clients seeking innovative solutions for challenging molecules[1][2][3][4].

Modalities: PeptidesOligonucleotidesMacrocyclic peptidesStapled peptides (including non-natural amino acids)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on PeptiStar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PeptiStar.

Explore the full profile